In addition to lipid metabolism, energy metabolism including glycolysis, glucose, and oxidative stress also sensitively respond to tau oligomer treatment in microglia40, suggesting that combination therapy targeting multiple aspects of microglial metabolic function may be needed for late phase of AD. The gene discussed is MAPT; the disease is Alzheimer disease.